NCT04599855: A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression
- State
- Completed
- Phase
- Phase 4
- People
- 477 taking part
- Started
- 4 Nov 2020
- Primary completion
- 31 Jan 2024
- Arms
- Placebo
- Results
- Posted on the registry
- 23 Oct 2020: Trial registered
- 4 Nov 2020: Trial started
- 31 Jan 2024: Trial completed
- 4 Mar 2025: Trial results posted